Christopher Longshaw
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 20
-
- Clostridium difficile and Clostridium perfringens research 11
- Antimicrobial Resistance in Staphylococcus 5
- Co-authors
- Mark H. Wilcox (9 shared papers)Jane Freeman (3 shared papers)Scott Nicholson (3 shared papers)Davide Manissero (7 shared papers)Jon J. Vernon (3 shared papers)K. Morris (2 shared papers)S. L. Todhunter (4 shared papers)Yoshinori Yamano (12 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (15 papers)Open Forum Infectious Diseases (8 papers)Clinical Microbiology and Infection (6 papers)Microbiology (2 papers)Antibiotics (2 papers)
- Partner nations
- United KingdomJapanUnited States
In The Last Decade
Christopher Longshaw
54 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 99
- Molecular Medicine 580
- Applied Microbiology and Biotechnology 169
- Infectious Diseases 872
- Critical Care and Intensive Care Medicine 122
- Endocrinology 110
Countries citing papers authored by Christopher Longshaw
This map shows the geographic impact of Christopher Longshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Longshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Longshaw more than expected).
Fields of papers citing papers by Christopher Longshaw
This network shows the impact of papers produced by Christopher Longshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Longshaw. The network helps show where Christopher Longshaw may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Longshaw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 217 | |
| 2 | 2017 | 147 | |
| 3 | 2016 | 146 | |
| 4 | 2021 | 115 | |
| 5 | 2017 | 109 | |
| 6 | 2020 | 104 | |
| 7 | 2005 | 101 | |
| 8 | 2002 | 80 | |
| 9 | 2020 | 70 | |
| 10 | 2020 | 66 | |
| 11 | 2020 | 63 | |
| 12 | 2000 | 59 | |
| 13 | 2012 | 52 | |
| 14 | 2022 | 48 | |
| 15 | 2002 | 46 | |
| 16 | 2021 | 44 | |
| 17 | 2013 | 41 | |
| 18 | 2013 | 39 | |
| 19 | 2021 | 38 | |
| 20 | 2021 | 37 |
About Christopher Longshaw
Christopher Longshaw is a scholar working on Molecular Medicine, Infectious Diseases, Pharmacology, Epidemiology and Applied Microbiology and Biotechnology, having authored 56 papers that have together received 1.9k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (20 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Clostridium difficile and Clostridium perfringens research (11 papers), Antibiotic Use and Resistance (9 papers), Bacterial Identification and Susceptibility Testing (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Urinary Tract Infections Management (4 papers) and Pneumonia and Respiratory Infections (3 papers). The work is most often cited by research in Molecular Medicine (580 citations), Applied Microbiology and Biotechnology (169 citations), Infectious Diseases (872 citations), Critical Care and Intensive Care Medicine (122 citations) and Endocrinology (110 citations). Christopher Longshaw has collaborated with scholars based in United Kingdom, Japan and United States. Frequent co-authors include Mark H. Wilcox, Jane Freeman, Scott Nicholson, Davide Manissero, Jon J. Vernon, K. Morris, S. L. Todhunter, Yoshinori Yamano, Anne Santerre Henriksen and Helen Ashwin. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Open Forum Infectious Diseases, Clinical Microbiology and Infection, Microbiology and Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.